{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:46:43Z","timestamp":1777078003620,"version":"3.51.4"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aims to analyze the differences in gut microbiota of patients with primary hypothyroidism before and after treatment and their correlations with clinical indicators. A total of 20 newly diagnosed primary hypothyroidism patients were selected for the study. These patients were treated with levothyroxine sodium (L-T4) for 12\u202fweeks, and fecal samples were collected before and after treatment. Concurrently, fecal samples from 20 healthy controls were also collected. High-throughput 16sRNA sequencing was conducted to analyze the composition of gut microbiota in each group. At the phylum level, the abundance of Bacteroidetes decreased in patients with primary hypothyroidism. After treatment, the abundance of Bacteroidetes increased, while the abundance of Proteobacteria and Desulfobacterota decreased. At the genus level, the abundance of\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    and\n                    <jats:italic>Faecalibacterium<\/jats:italic>\n                    decreased, while the abundance of\n                    <jats:italic>Collinsella<\/jats:italic>\n                    ,\n                    <jats:italic>Klebsiella<\/jats:italic>\n                    ,\n                    <jats:italic>Parabacteroides<\/jats:italic>\n                    , and the genus\n                    <jats:italic>Koalarothia<\/jats:italic>\n                    increased. After treatment, the abundance of\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    ,\n                    <jats:italic>Ruminococcusgnavus<\/jats:italic>\n                    ,\n                    <jats:italic>Megamonas<\/jats:italic>\n                    and\n                    <jats:italic>Corrococcus<\/jats:italic>\n                    increased, while the abundance of\n                    <jats:italic>Escherichia-Shigella<\/jats:italic>\n                    ,\n                    <jats:italic>Agaricus<\/jats:italic>\n                    ,\n                    <jats:italic>Ruminococcus torques<\/jats:italic>\n                    ,\n                    <jats:italic>Koalarothia<\/jats:italic>\n                    , and\n                    <jats:italic>Blautia<\/jats:italic>\n                    decreased. Differential species screening showed 24 different species between the pre-treatment and post-treatment groups. Spearman correlation analysis showed that\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    was positively correlated with TT3, TT4, and FT4, and negatively correlated with AST;\n                    <jats:italic>R.\u00a0torques<\/jats:italic>\n                    was negatively correlated with TT4 and FT4; Koalarothia was positively correlated with TgAb and TC;\n                    <jats:italic>Blautia<\/jats:italic>\n                    was positively correlated with TPOAb. Patients with primary hypothyroidism exhibit gut microbiota dysbiosis, with a decrease in the abundance of certain short-chain fatty acid-producing bacteria, which increases after treatment. There is a certain correlation between specific gut microbiota and thyroid function as well as lipid metabolism indicators.\n                  <\/jats:p>","DOI":"10.1515\/biol-2025-1307","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:12:38Z","timestamp":1777075958000},"source":"Crossref","is-referenced-by-count":0,"title":["Changes in gut microbiota before and after treatment in patients with primary hypothyroidism"],"prefix":"10.1515","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7197-7320","authenticated-orcid":false,"given":"Qian","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Endocrinology , 920th Hospital of the Joint Logistics Support Force of the Chinese People\u2019s Liberation Army , Kunming , China"},{"name":"Department of Endocrinology , Bijie Traditional Chinese Medicine Hospital , Bijie , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiaSheng","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , Zhujiang Hospital of Southern Medical University , Guangzhou , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3165-1485","authenticated-orcid":false,"given":"Xiang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , 920th Hospital of the Joint Logistics Support Force of the Chinese People\u2019s Liberation Army , Kunming , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YaPing","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , 920th Hospital of the Joint Logistics Support Force of the Chinese People\u2019s Liberation Army , Kunming , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiaYun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , 920th Hospital of the Joint Logistics Support Force of the Chinese People\u2019s Liberation Army , Kunming , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HaiBing","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , 920th Hospital of the Joint Logistics Support Force of the Chinese People\u2019s Liberation Army , Kunming , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2026042500123198103_j_biol-2025-1307_ref_001","doi-asserted-by":"crossref","unstructured":"Heged\u00fcs, L, Bianco, AC, Jonklaas, J, Pearce, SH, Weetman, AP, Perros, P. Primary hypothyroidism and quality of life. Nat Rev Endocrinol 2022;18:230\u201342. https:\/\/doi.org\/10.1038\/s41574-021-00625-8.","DOI":"10.1038\/s41574-021-00625-8"},{"key":"2026042500123198103_j_biol-2025-1307_ref_002","doi-asserted-by":"crossref","unstructured":"Knezevic, J, Starchl, C, Tmava Berisha, A, Amrein, K. Thyroid-gut-axis: how does the microbiota influence thyroid function? Nutrients 2020;12:1769. https:\/\/doi.org\/10.3390\/nu12061769.","DOI":"10.3390\/nu12061769"},{"key":"2026042500123198103_j_biol-2025-1307_ref_003","doi-asserted-by":"crossref","unstructured":"Jiang, T, Yang, XQ, Wu, BH, Tao, RC, Chen, RB, Jin, LB, et al.. Gut microbiota in hypothyroidism: pathogenic mechanisms and opportunities for precision microbiome interventions. Front Microbiol 2025;16:1661211. https:\/\/doi.org\/10.3389\/fmicb.2025.1661211.","DOI":"10.3389\/fmicb.2025.1661211"},{"key":"2026042500123198103_j_biol-2025-1307_ref_004","doi-asserted-by":"crossref","unstructured":"Knezevic, J, Starchl, C, Berisha, AT, Amerin, K. Thyroid-gut-axis: how does the microbiota influence thyroid function? Nutrients 2020;12:1769. https:\/\/doi.org\/10.3390\/nu12061769.","DOI":"10.3390\/nu12061769"},{"key":"2026042500123198103_j_biol-2025-1307_ref_005","doi-asserted-by":"crossref","unstructured":"Arora, M, Mahat, RK, Kumar, S, Mustafa, I, Sah, SP. Study of trace elements in patients of hypothyroidism with special reference to zinc and copper. Biomed J 2018;2.","DOI":"10.26717\/BJSTR.2018.06.001336"},{"key":"2026042500123198103_j_biol-2025-1307_ref_006","doi-asserted-by":"crossref","unstructured":"Shulhai, AM, Rotondo, R, Petraroli, M, Patianna, V, Predieri, B, Lughetti, L, et al.. The role of nutrition on thyroid function. Nutrients 2024;16:2496. https:\/\/doi.org\/10.3390\/nu16152496.","DOI":"10.3390\/nu16152496"},{"key":"2026042500123198103_j_biol-2025-1307_ref_007","doi-asserted-by":"crossref","unstructured":"Cayres, LCF, de Salis, LVV, Rodrigues, GSP, Lengert, AVH, Biondi, APC, Sargentini, LDB, et al.. Detection of alterations in the gut microbiota and intestinal permeability in patients with Hashimoto thyroiditis. Front Immunol 2021;12:579140. https:\/\/doi.org\/10.3389\/fimmu.2021.579140.","DOI":"10.3389\/fimmu.2021.579140"},{"key":"2026042500123198103_j_biol-2025-1307_ref_008","doi-asserted-by":"crossref","unstructured":"Virili, C, Centanni, M. \u201cWith a little help from my friends\u201d\u00a0\u2013\u00a0the role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Mol Cell Endocrinol 2017;458:39\u201343. https:\/\/doi.org\/10.1016\/j.mce.2017.01.053.","DOI":"10.1016\/j.mce.2017.01.053"},{"key":"2026042500123198103_j_biol-2025-1307_ref_009","doi-asserted-by":"crossref","unstructured":"Virili, C, Stramazzo, I, Centanni, M. Gut microbiome and thyroid autoimmunity. Best Pract Res Clin Endocrinol Metab 2021;35:101506. https:\/\/doi.org\/10.1016\/j.beem.2021.101506.","DOI":"10.1016\/j.beem.2021.101506"},{"key":"2026042500123198103_j_biol-2025-1307_ref_010","doi-asserted-by":"crossref","unstructured":"Roszkowska, P, Klimczak, E, Ostrycharz, E, R\u0105czka, A, Wojciechowska-Koszko, I, Dybus, A, et al.. Small intestinal bacterial overgrowth (SIBO) and twelve groups of related diseases\u00a0\u2013\u00a0current state of knowledge. Biomedicines 2024;12:1030. https:\/\/doi.org\/10.3390\/biomedicines12051030.","DOI":"10.3390\/biomedicines12051030"},{"key":"2026042500123198103_j_biol-2025-1307_ref_011","doi-asserted-by":"crossref","unstructured":"Woting, A, Blaut, M. The intestinal microbiota in metabolic disease. Nutrients 2016;8:202. https:\/\/doi.org\/10.3390\/nu8040202.","DOI":"10.3390\/nu8040202"},{"key":"2026042500123198103_j_biol-2025-1307_ref_012","doi-asserted-by":"crossref","unstructured":"Mariat, D, Firmesse, O, Levenez, F, Guimar\u0103es, V, Sokol, H, Dor\u00e9, J, et al.. The Firmicutes\/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009;9:123. https:\/\/doi.org\/10.1186\/1471-2180-9-123.","DOI":"10.1186\/1471-2180-9-123"},{"key":"2026042500123198103_j_biol-2025-1307_ref_013","doi-asserted-by":"crossref","unstructured":"Gibiino, G, Lopetuso, LR, Scaldaferri, F, Rizzatti, G, Binda, C, Gasbarrini, A. Exploring Bacteroidetes: metabolic key points and immunological tricks of our gut commensals. Dig Liver Dis 2018;50:635\u20139. https:\/\/doi.org\/10.1016\/j.dld.2018.03.016.","DOI":"10.1016\/j.dld.2018.03.016"},{"key":"2026042500123198103_j_biol-2025-1307_ref_014","doi-asserted-by":"crossref","unstructured":"Biscarini, F, Masetti, G, Muller, I, Verhasselt, HL, Covelli, D, Colucci, G, et al.. Gut microbiome associated with Graves disease and Graves orbitopathy: the INDIGO Multicenter European Study. J\u00a0Clin Endocrinol Metab 2023;108:2065\u201377. https:\/\/doi.org\/10.1210\/clinem\/dgad030.","DOI":"10.1210\/clinem\/dgad030"},{"key":"2026042500123198103_j_biol-2025-1307_ref_015","doi-asserted-by":"crossref","unstructured":"Chen, J, Qin, Q, Yan, S, Yang, Y, Yan, H, Li, T, et al.. Gut microbiome alterations in patients with carotid atherosclerosis. Front Cardiovasc Med 2021;8:739093. https:\/\/doi.org\/10.3389\/fcvm.2021.739093.","DOI":"10.3389\/fcvm.2021.739093"},{"key":"2026042500123198103_j_biol-2025-1307_ref_016","doi-asserted-by":"crossref","unstructured":"Bargiel, P, Szczuko, M, Stachowska, L, Prowans, P, Czapla, N, Markowska, M, et al.. Microbiome metabolites and thyroid dysfunction. J\u00a0Clin Med 2021;10:3609. https:\/\/doi.org\/10.3390\/jcm10163609.","DOI":"10.3390\/jcm10163609"},{"key":"2026042500123198103_j_biol-2025-1307_ref_017","doi-asserted-by":"crossref","unstructured":"Zhang, J, Guo, Z, Xue, Z, Sun, Z, Zhang, M, Wang, L, et al.. A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME J 2015;9:1979\u201390. https:\/\/doi.org\/10.1038\/ismej.2015.11.","DOI":"10.1038\/ismej.2015.11"},{"key":"2026042500123198103_j_biol-2025-1307_ref_018","unstructured":"Wu, XK, Ma, CF, Yu, PB, Wang, XL, Han, L, Li, MX, et al.. Significance of the quantitative analysis of Lactobacillus and Peptostreptococcus productus of gut microbiota in patients with type 2 diabetes. Xi\u2019an Jiaot Daxue Xuebao (Yixue Ban) 2015;36:93\u20137."},{"key":"2026042500123198103_j_biol-2025-1307_ref_019","unstructured":"Deng, MQ, Liu, H, Xiao, T, Zheng, XF, Chen, LP. Analysis of distribution and drug resistance of Streptococcus in a third grade A hospital from 2012 to 2020. Lab Med Clin 2021;19:2929\u201332, 2936."},{"key":"2026042500123198103_j_biol-2025-1307_ref_020","doi-asserted-by":"crossref","unstructured":"Schirmer, M, Garner, A, Vlamakis, H, Xavier, RJ. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol 2019;17:497\u2013511. https:\/\/doi.org\/10.1038\/s41579-019-0213-6.","DOI":"10.1038\/s41579-019-0213-6"},{"key":"2026042500123198103_j_biol-2025-1307_ref_021","doi-asserted-by":"crossref","unstructured":"Zhao, H, Yuan, L, Zhu, D, Sun, B, Du, J, Wang, J, et al.. Alterations and mechanism of gut microbiota in Graves\u2019 disease and Hashimoto\u2019s thyroiditis. Pol J Microbiol 2022;71:173\u201389. https:\/\/doi.org\/10.33073\/pjm-2022-016.","DOI":"10.33073\/pjm-2022-016"},{"key":"2026042500123198103_j_biol-2025-1307_ref_022","doi-asserted-by":"crossref","unstructured":"Biernat, KA, Pellock, SJ, Bhatt, AP, Bivins, MM, Walton, WG, Tran, BNT, et al.. Structure, function, and inhibition of drug reactivating human gut microbial \u03b2-glucuronidases. Sci Rep 2019;9:825. https:\/\/doi.org\/10.1038\/s41598-018-36069-w.","DOI":"10.1038\/s41598-018-36069-w"},{"key":"2026042500123198103_j_biol-2025-1307_ref_023","doi-asserted-by":"crossref","unstructured":"Schaus, SR, Vasconcelos Pereira, G, Luis, AS, Madlambayan, E, Terrapon, N, Ostrowski, MP, et al.. Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by Bacteroides thetaiotaomicron. mBio 2024;15:e00039\u201324. https:\/\/doi.org\/10.1128\/mbio.00039-24.","DOI":"10.1128\/mbio.00039-24"},{"key":"2026042500123198103_j_biol-2025-1307_ref_024","doi-asserted-by":"crossref","unstructured":"Ma, HY, Xu, J, Liu, X, Zhu, Y, Gao, B, Karin, M, et al.. The role of IL-17 signaling in regulation of the liver\u2013brain axis and intestinal permeability in alcoholic liver disease. Curr Pathobiol Rep 2016;4:27\u201335. https:\/\/doi.org\/10.1007\/s40139-016-0097-3.","DOI":"10.1007\/s40139-016-0097-3"},{"key":"2026042500123198103_j_biol-2025-1307_ref_025","doi-asserted-by":"crossref","unstructured":"Pihelgas, S, Ehala-Aleksejev, K, Kuldj\u00e4rv, R, J\u00f5eleht, A, Kazantseva, J, Adamberg, K. Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers. FEMS Microbes 2024;5:xtae001. https:\/\/doi.org\/10.1093\/femsmc\/xtae001.","DOI":"10.1093\/femsmc\/xtae001"},{"key":"2026042500123198103_j_biol-2025-1307_ref_026","doi-asserted-by":"crossref","unstructured":"Talebi, S, Karimifar, M, Heidari, Z, Mohammadi, H, Askari, G. The effects of synbiotic supplementation on thyroid function and inflammation in hypothyroid patients: a randomized, double-blind, placebo-controlled trial. Complement Ther Med 2020;48:102234. https:\/\/doi.org\/10.1016\/j.ctim.2019.102234.","DOI":"10.1016\/j.ctim.2019.102234"},{"key":"2026042500123198103_j_biol-2025-1307_ref_027","doi-asserted-by":"crossref","unstructured":"Spaggiari, G, Brigante, G, De Vincentis, S, Cattini, U, Roli, L, De Santis, MC, et al.. Probiotics ingestion does not directly affect thyroid hormonal parameters in hypothyroid patients on levothyroxine treatmen. Front Endocrinol 2017;8:316. https:\/\/doi.org\/10.3389\/fendo.2017.00316.","DOI":"10.3389\/fendo.2017.00316"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1307\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1307\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:12:48Z","timestamp":1777075968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1307\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/biol-2025-1307"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1307","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20251307"}}